Vastarel contains the active ingredient trimetazidine, a metabolic agent used to improve cardiac efficiency. It is available in a 20 mg capsule formulation and is classified as a prescription medication for heart-related conditions. In Hong Kong, the product is regulated by the Department of Health and must be prescribed by a qualified healthcare professional.
Trimetazidine acts at the cellular level by shifting heart muscle energy production from fatty-acid oxidation toward glucose oxidation. This metabolic shift requires less oxygen, helping the heart maintain function during periods of reduced blood flow (ischemia).
These indications are recognized by regulatory authorities in Hong Kong and align with the product’s labeling in other jurisdictions.
Current peer-reviewed literature does not provide strong evidence for routine off-label use of trimetazidine. Emerging research has explored its potential benefit in heart failure with preserved ejection fraction, but such use remains investigational and should only be considered under specialist supervision.
Disclaimer: Off-label use requires medical supervision and individualized risk assessment.
If any of these occur, seek medical attention promptly.
This article provides educational information about Vastarel and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
Vastarel is a branded formulation of trimetazidine that contains 20 mg of the active ingredient per capsule. Generic versions contain the same amount of trimetazidine but may differ in inactive ingredients, appearance, or packaging.
Trimetazidine is not known to trigger migraines, but individual responses vary. Discuss your migraine history with a healthcare professional before starting the medication.
Clinical improvement often becomes noticeable within a few days of regular dosing, but full therapeutic benefit may take several weeks as the heart adapts to the metabolic changes.
There are no specific food restrictions, but maintaining a balanced diet low in saturated fats supports overall heart health and complements the medication’s effects.
Trimetazidine is not part of routine occupational drug screens, but it is listed on the World Anti-Doping Agency (WADA) prohibited list. Athletes should verify sport-specific regulations before use.
Yes, you may carry your prescribed capsules in hand luggage, provided they are in their original packaging with a clear prescription label. Keep them easily accessible for security inspection.
Do not induce vomiting. Seek immediate medical attention or contact a poison control center for guidance, as the dosage may exceed the recommended amount.
Mild hepatic impairment generally does not require dose modification, but liver function should be evaluated periodically, and any concerns discussed with a prescriber.
Beta-blockers reduce heart rate and contractility, while Vastarel improves the heart’s metabolic efficiency without affecting heart rate. They can be used together, but a clinician should tailor therapy to each patient’s needs.
Brand-name products often carry a higher price due to branding and distribution costs. Generic equivalents usually offer a lower-cost option, though exact pricing varies among pharmacies and insurance coverage.
